Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring.

Objective: The international consensus on continuous glucose monitoring (CGM) recommends time in range (TIR) target of >70% for pregnant people. Our aim was to compare outcomes between pregnant people with TIR ≤ versus >70%.

Study Design: This study was a retrospective study of all people using CGM during pregnancy from January 2017 to May 2021 at a tertiary care center.

Maternal Education Level Among People with Diabetes and Associated Adverse Outcomes.

Objective: The aim of the study is to determine the relation between education and adverse outcomes in individuals with pregestational or gestational diabetes.

Study Design: This population-based cohort study, using the U.S.

Type 2 diabetes and neonatal hypoglycemia: role of route of delivery and insulin infusion.

Objective: To compare the rate of neonatal hypoglycemia among newborns delivered by individuals with Type 2 diabetes mellitus (T2DM) in two clinical scenarios: who attempted vaginal delivery vs. had a planned cesarean delivery (CD); who had intrapartum insulin infusion vs. who did not.

Detemir vs neutral protamine Hagedorn insulin for diabetes mellitus in pregnancy: a comparative effectiveness, randomized controlled trial.

Background: Insulin detemir, being used increasingly during pregnancy, may have pharmacologic benefits compared with neutral protamine Hagedorn.

Objective: We evaluated the probability that compared with treatment with neutral protamine Hagedorn, treatment with insulin detemir reduces the risk for adverse neonatal outcome among individuals with type 2 or overt type 2 diabetes mellitus (gestational diabetes mellitus diagnosed at <20 weeks' gestation).

Study Design: We performed a multiclinic randomized controlled trial (September 2018 to January 2020), which included women with singleton gestation with type 2 or overt type 2 diabetes mellitus who sought obstetrical care at ≤21 weeks' gestation.